Items where Author is "Arntz, O. J."

2011

Geurts, J. and Vermeij, E. A. and Pohlers, D. and Arntz, O. J. and Kinne, R. W. and van den Berg, W. B. and van de Loo, F. A.. (2011) A novel Saa3-promoter reporter distinguishes inflammatory subtypes in experimental arthritis and human synovial fibroblasts. Annals of the Rheumatic Diseases, 70 (7). pp. 1311-1319.

Geurts, J. and van den Brand, B. T. and Wolf, A. and Abdollahi-Roodsaz, S. and Arntz, O. J. and Kracht, M. and van den Berg, W. B. and van de Loo, F. A.. (2011) Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts. Rheumatology, 50 (7). pp. 1216-1225.

2010

Arntz, O. J. and Geurts, J. and Veenbergen, S. and Bennink, M. B. and van den Brand, B. T. and Abdollahi-Roodsaz, S. and van den Berg, W. B. and van de Loo, F. A.. (2010) A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis. Arthritis Research and Therapy, 12 (2). R61.

2009

Geurts, J. and Joosten, L. A. and Takahashi, N. and Arntz, O. J. and Gluck, A. and Bennink, M. B. and van den Berg, W. B. and van de Loo, F. A.. (2009) Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritis. Molecular Therapy, 17 (11). pp. 1877-1887.

2007

Geurts, J. and Arntz, O. J. and Bennink, M. B. and Joosten, L. A. and van den Berg, W. B. and van de Loo, F. A.. (2007) Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis. Gene Therapy, 14 (23). pp. 1632-1638.